A Randomised Phase II Trial of Adjuvant Avelumab in Patients with Early Stage Merkel Cell Carcinoma

  • Xu, Wen (Primary Chief Investigator (PCI))
  • Poulsen, Michael (Chief Investigator (CI))
  • Atkinson, Victoria (Chief Investigator (CI))
  • Fogarty, Gerald B (Chief Investigator (CI))
  • Veness, Michael (Chief Investigator (CI))
  • Smithers, Bernard Mark (Chief Investigator (CI))
  • Gyorki, David (Chief Investigator (CI))
  • Mar, Victoria (Chief Investigator (CI))
  • Howle, Julie (Chief Investigator (CI))
  • Guminski, Alexander (Chief Investigator (CI))

Project: Research

Project Details

Short titleAdjuvant therapy for Merkel Cell Cancer
AcronymI-MAT
StatusActive
Effective start/end date1/04/19 → 31/03/26